Opportunity Information: Apply for RFA DD 14 002

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Research Approaches to Improve the Care and Outcomes of" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.315 Rare Disorders Research, Surveillance, Health Promotion, and Education.
  • This funding opportunity was created on Feb 25, 2014 and posted on Feb 25, 2014.
  • Applicants must submit their applications by Mar 12, 2014 Key Dates Letter of Intent Due Date February 7, 2014, Application Due Date March 12, 2014, by 1159 PM U.S. Eastern Time.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $10,500,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $800,000.00 in funding.
  • The number of recipients for this funding is limited to 30 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Section III. Eligibility Information 1. Eligible Applicants Eligible Organizations Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education Nonprofits (Other than Institutions of Higher Education) For Profit Organizations Small Businesses For Profit Organizations (Other than Small Businesses) Governments State Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Eligible Agencies of the Federal Government U.S. Territory or Possession Other Native American tribal organizations (other than Federally recognized tribal governments) Faith based or Community based Organizations Regional Organizations Bona Fide Agents a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. Federally Funded Research and Development Centers (FFRDCs) FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not for profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long term research or development need which cannot be met as effectively by an agency s existing in house or contractor resources. FFRDCs enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to http://ecfr.gpoaccess.gov/cgi/t/text/text idxcecfrsid512ff78311f427c00454772dcf21523argndiv8viewtextnode481.0.1.6.34.0.1.18idno48
Apply for RFA DD 14 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The CDC grant opportunity "Research Approaches to Improve the Care and Outcomes of" (Funding Opportunity Number RFA DD 14 002) is a discretionary grant program focused on improving clinical care, health outcomes, and practical educational or informational resources for people living with spina bifida (SB). The central aim is to strengthen how SB care is delivered across clinics by building systems that can monitor what care is being provided, compare outcomes across sites, and use real-world data to identify and spread best practices. In total, the opportunity is structured around three connected components that range from building care-monitoring infrastructure, to continuing long-term patient data collection, to testing a focused clinical protocol intended to protect kidney health in very young children.

Component A concentrates on creating the infrastructure for a Spina Bifida Clinical Care Monitoring and Tracking (CCMT) system. The intent is not simply to collect information, but to put a functioning framework in place that can routinely monitor, track, and evaluate patterns of care across SB clinics. The larger goal is to improve and standardize care through evidence-based effectiveness analysis, meaning clinics can compare what they do, see which approaches are linked with better outcomes, and align clinical practice with proven strategies. This CCMT system is also expected to strengthen coordination and communication between SB clinics and SB chapters, help inform research priorities for the National Spina Bifida Patient Registry (NSBPR), and encourage adoption of best practices identified through the NSBPR, the Urologic Protocol for Pediatric Patients/UPPF (as referenced in the announcement), and other credible sources.

Component B supports ongoing collection of longitudinal data for both children and adults with SB, emphasizing long-term tracking rather than one-time snapshots. These data are intended to drive quality improvement by allowing comparisons across clinics, particularly comparisons of interventions and resulting outcomes. The point is to use variation in practice as an opportunity to learn what works best in real clinical settings, then translate those findings into better care standards. Component B also explicitly supports hypothesis generation, using NSBPR data to propose research questions that can later be developed and tested, which helps turn routine clinical data into a pipeline for continuous improvement and targeted research.

Component C is more narrowly clinical and intervention-focused: it funds the implementation and evaluation of a best practice protocol for urinary system management in infants and young children with SB, with kidney function preservation highlighted as a key positive health outcome. The emphasis is on moving toward an evidence-based protocol, meaning the funded work should help determine whether a structured approach to early urologic management leads to better kidney outcomes and could be adopted more broadly. A major structural rule applies here: any applicant seeking Component C funds must also apply for Component B, and only organizations funded under Component B will be eligible to be considered for Component C funding. This requirement aligns with the logic of the program, since evaluating a clinical protocol depends on strong, consistent longitudinal data collection and outcome tracking.

From an administrative standpoint, this opportunity was posted February 25, 2014, with a letter of intent due February 7, 2014, and a full application due March 12, 2014 (by 11:59 PM U.S. Eastern Time). The program anticipated up to 30 awards, with an estimated total funding amount of $10.5 million and an award ceiling of $800,000. There was no cost sharing or matching requirement. The activity category is health, and the CFDA number listed is 93.315 (Rare Disorders Research, Surveillance, Health Promotion, and Education). The announcement was later archived April 11, 2014.

Eligibility was broad and included many organization types, such as public and private institutions of higher education (including minority-serving institutions like HBCUs, HSIs, TCCUs, and Alaska Native and Native Hawaiian-serving institutions), nonprofits, for-profit organizations (including small businesses), and multiple levels of government (state, county, city/township, special district, tribal governments, territories). It also allowed eligible federal agencies, faith-based and community-based organizations, regional organizations, and Federally Funded Research and Development Centers (FFRDCs). The FOA also described how a "bona fide agent" could apply on behalf of a state or local government, provided a legal binding agreement documenting that status is included in the application package.

Overall, the grant is designed to tighten the connection between clinical practice, continuous data-driven learning, and implementation of best practices in spina bifida care. It pushes beyond basic surveillance by emphasizing infrastructure that supports communication and coordinated improvement, robust longitudinal data collection through the NSBPR framework, and targeted evaluation of a high-impact clinical protocol area (early urinary management) where improved consistency and evidence could directly affect long-term health outcomes like kidney preservation. For technical assistance accessing the full announcement, the CDC Procurement and Grants Office Technical Information Management Section (TIMS) was listed as the contact point (phone 770-488-2700, email pgotim@cdc.gov).

Frequently Asked Questions (FAQs)

What is the name and funding opportunity number for this CDC grant?

The opportunity is titled "Research Approaches to Improve the Care and Outcomes of" and the Funding Opportunity Number (FON) is RFA DD 14 002.

What is the overall purpose of this funding opportunity?

This discretionary grant program focuses on improving clinical care, health outcomes, and practical educational or informational resources for people living with spina bifida (SB). A central goal is to strengthen how SB care is delivered across clinics by building systems that can monitor what care is provided, compare outcomes across sites, and use real-world data to identify and spread best practices.

How is the program structured?

The opportunity is organized into three connected components: (A) building care-monitoring infrastructure through a Clinical Care Monitoring and Tracking system, (B) continuing longitudinal patient data collection for children and adults with SB, and (C) implementing and evaluating a best-practice urologic protocol for infants and young children to support kidney health.

What is Component A?

Component A focuses on creating the infrastructure for a Spina Bifida Clinical Care Monitoring and Tracking (CCMT) system. The intent is to establish a functioning framework to routinely monitor, track, and evaluate patterns of care across SB clinics, enabling evidence-based effectiveness analysis and supporting improvements and standardization of care across sites.

What is the CCMT system expected to do beyond collecting data?

The CCMT system is intended to support routine monitoring and evaluation of care patterns across clinics, enable comparisons across sites, and help clinics align practices with approaches linked to better outcomes. It is also expected to strengthen coordination and communication between SB clinics and SB chapters, help inform research priorities for the National Spina Bifida Patient Registry (NSBPR), and encourage adoption of best practices identified through NSBPR, the Urologic Protocol for Pediatric Patients/UPPF (as referenced in the announcement), and other credible sources.

What is Component B?

Component B supports ongoing longitudinal data collection for both children and adults with spina bifida. The emphasis is on long-term tracking rather than one-time snapshots, using data to drive quality improvement and enable comparisons across clinics, including comparisons of interventions and resulting outcomes.

How are the Component B data intended to be used?

Component B data are intended to support quality improvement by allowing clinics to compare interventions and outcomes across sites. The program aims to use real-world variation in clinical practice as an opportunity to learn what works best in routine settings and translate those insights into better care standards.

Does Component B support research activity?

Yes. Component B explicitly supports hypothesis generation by using NSBPR data to propose research questions that can later be developed and tested, turning routine clinical data into a pipeline for continuous improvement and targeted research.

What is Component C?

Component C funds the implementation and evaluation of a best practice protocol for urinary system management in infants and young children with spina bifida, with preservation of kidney function highlighted as a key positive health outcome. The goal is to help determine whether a structured approach to early urologic management improves kidney outcomes and could be adopted more broadly.

Is there a special eligibility rule for applying to Component C?

Yes. Any applicant seeking Component C funds must also apply for Component B. Additionally, only organizations funded under Component B will be eligible to be considered for Component C funding.

Why does Component C require Component B?

The requirement reflects the program logic described in the opportunity: evaluating a clinical protocol depends on strong, consistent longitudinal data collection and outcome tracking, which is the focus of Component B.

When was this funding opportunity posted and when was it archived?

The opportunity was posted on February 25, 2014, and later archived on April 11, 2014.

What were the due dates for the letter of intent and the full application?

The letter of intent was due February 7, 2014. The full application was due March 12, 2014, by 11:59 PM U.S. Eastern Time.

How many awards were anticipated and what was the estimated total funding?

The program anticipated up to 30 awards, with an estimated total funding amount of $10.5 million.

What was the award ceiling?

The award ceiling listed for this opportunity was $800,000.

Was cost sharing or matching required?

No. The opportunity stated there was no cost sharing or matching requirement.

What is the activity category and CFDA number for this opportunity?

The activity category is health. The CFDA number listed is 93.315 (Rare Disorders Research, Surveillance, Health Promotion, and Education).

Who was eligible to apply?

Eligibility was broad and included public and private institutions of higher education (including minority-serving institutions such as HBCUs, HSIs, TCCUs, and Alaska Native and Native Hawaiian-serving institutions), nonprofits, for-profit organizations (including small businesses), and multiple levels of government (state, county, city/township, special district, tribal governments, and U.S. territories). The opportunity also allowed eligible federal agencies, faith-based and community-based organizations, regional organizations, and Federally Funded Research and Development Centers (FFRDCs).

Can a "bona fide agent" apply on behalf of a state or local government?

Yes. The FOA described that a "bona fide agent" could apply on behalf of a state or local government, provided the application includes a legal binding agreement documenting that status.

What is the National Spina Bifida Patient Registry (NSBPR) role in this opportunity?

NSBPR is referenced as a key framework for longitudinal data collection and learning across clinics. The opportunity emphasizes using NSBPR-related data to compare outcomes, generate hypotheses for future research questions, inform research priorities, and support the adoption of best practices identified through NSBPR and related credible sources.

What types of outcomes and improvements does the program aim to support?

The opportunity emphasizes improved clinical care delivery across SB clinics, stronger monitoring and tracking of care patterns, better coordination and communication across clinics and SB chapters, evidence-based effectiveness analysis to identify best practices, and improved patient outcomes. Component C specifically highlights kidney function preservation in infants and young children through improved early urinary system management.

Where can applicants get technical assistance or request access to the full announcement?

Technical assistance was available through the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700 or pgotim@cdc.gov.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Measurement Science and Engineering (MSE) Research Grant Programs

Previous opportunity: Health Promotion and Disease Prevention Research Centers Special Interest Project Competitive Supplements (SIPs)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DD 14 002

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DD 14 002) also looked into and applied for these:

Funding Opportunity
Silvio O. Conte Centers for Basic or Translational Mental Health Research (P50) Apply for PAR 14 120

Funding Number: PAR 14 120
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Consortium for Food Allergy Research (U19) Apply for RFA AI 14 003

Funding Number: RFA AI 14 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Health Impact Assessment for Improved Community Design Apply for CDC RFA EH14 1407

Funding Number: CDC RFA EH14 1407
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $145,000
Strengthening the National Institutes of Health in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 115804CONT14

Funding Number: CDC RFA GH11 115804CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Strengthening Human Resources for Health through Continuing Education of Health Workers in the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 116704CONT14

Funding Number: CDC RFA GH11 116704CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Demographic Surveillance Study support in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1110104CONT14

Funding Number: CDC RFA GH11 1110104CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Surveillance and Research of Muscular Dystrophies and Neuromuscular Disorders Apply for RFA DD 14 001

Funding Number: RFA DD 14 001
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Increasing the Capacity of the Government of Barbados to expand Coordinated HIV Prevention, Strategic Information, and Laboratory Programs under the Presidents Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 120403CONT14

Funding Number: CDC RFA GH12 120403CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Initiative for Maximizing Student Development (IMSD) (R25) Apply for PAR 14 121

Funding Number: PAR 14 121
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improving Health Surveillance through Networking, Regional Coordination and Strengthening of Technology, Communication and Training in Epidemiology to Improve Emergency Response in Publich Health under the International Health Regulations and the Hea Apply for CDC RFA GH10 100505CONT14

Funding Number: CDC RFA GH10 100505CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Alcohol Induced Effects on Tissue Injury and Repair (R21) Apply for PA 14 124

Funding Number: PA 14 124
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Alcohol Induced Effects on Tissue Injury and Repair (R01) Apply for PA 14 123

Funding Number: PA 14 123
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Strengthening Adherence to Antiretroviral Based HIV Treatment and Prevention (R21) Apply for PA 14 125

Funding Number: PA 14 125
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Strengthening Adherence to Antiretroviral Based HIV Treatment and Prevention (R01) Apply for PA 14 126

Funding Number: PA 14 126
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders Apply for CDC RFA DD14 1409

Funding Number: CDC RFA DD14 1409
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Care (R01) Apply for PA 14 127

Funding Number: PA 14 127
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Targeted Basic Behavioral and Social Science and Intervention Development for HIV Prevention and Care (R21) Apply for PA 14 128

Funding Number: PA 14 128
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R21) Apply for PA 14 129

Funding Number: PA 14 129
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Accelerating Improvements in the HIV Care Continuum (R21) Apply for PA 14 130

Funding Number: PA 14 130
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Improving Delivery of HIV Prevention and Treatment through Implementation Science and Translational Research (R01) Apply for PA 14 131

Funding Number: PA 14 131
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DD 14 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.